The second generation of BCR-ABL tyrosine kinase inhibitors
T Tauchi, K Ohyashiki - International journal of hematology, 2006 - Springer
Imatinib was developed as the first molecularly targeted therapy to specifically inhibit the
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
[引用][C] The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
T Tauchi, K Ohyashiki - International Journal of Hematology, 2006 - cir.nii.ac.jp
The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の …
情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の …
[引用][C] The second generation of BCR-ABL tyrosine kinase inhibitors: PIH: New era of leukemia therapy
T TAUCHI, K OHYASHIKI - International journal of hematology, 2006 - pascal-francis.inist.fr
The second generation of BCR-ABL tyrosine kinase inhibitors : PIH: New era of leukemia
therapy CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
therapy CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
The second generation of BCR-ABL tyrosine kinase inhibitors
T Tauchi, K Ohyashiki - International journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Imatinib was developed as the first molecularly targeted therapy to specifically inhibit the
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
T Tauchi, K Ohyashiki - International Journal of Hematology, 2006 - infona.pl
Imatinib was developed as the first molecularly targeted therapy to specifically inhibit the
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
The second generation of BCR-ABL tyrosine kinase inhibitors.
T Tauchi, K Ohyashiki - International Journal of Hematology, 2006 - europepmc.org
Imatinib was developed as the first molecularly targeted therapy to specifically inhibit the
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
T Tauchi, K Ohyashiki - International Journal of Hematology, 2006 - search.proquest.com
Imatinib was developed as the first molecularly targeted therapy to specifically inhibit the
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
BCR-ABL kinase in Philadelphia chromosome (Ph)-positive chronic myeloid leukemia …
[引用][C] The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
O Kazuma - International journal of hematology, 2006 - cir.nii.ac.jp
The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …